Argus Pharmaceuticals Inc., Oncologix Inc. cancer, infectious diseases news

ARGS said the Delaware Chancery Court denied a temporary restraining order sought by a group of Oncologix shareholders who are challenging the proposed merger of Oncologix with ARGS's Triplex Pharmaceutical Corp. subsidiary (see BioCentury Feb. 27). ...